Deletions of the long arm of chromosome 20 have been reported in a wide range of myeloid disorders and may re¯ect loss of critical tumor suppressor gene(s). To identify such candidate genes, 65 human myeloid cell line DNAs were screened by polymerase chain reaction (PCR) for evidence of allelic loss at 39 highly polymorphic loci on the long arm of chromosome 20. A mono-allelic pattern was present in eight cell lines at multiple adjacent loci spanning the common deleted regions (CDRs) previously de®ned in primary hematological samples, suggesting loss of heterozygosity (LOH) at 20q. Fluorescence in situ hybridization (FISH) was then performed using a series of yeast arti®cial chromosomes (YACs) ordered in the CDR, and in ®ve of eight cell lines, the deletions resulted from cytogenetically detectable whole chromosomal loss or large interstitial deletion, whereas in another cell line deletion was associated with an unbalanced translocation. LOH in the CMK megakaryocytic cell line, which has a hypotetraploid karyotype, was associated with a der(20)t(1;20)(q32;q12)x2 leading to complete deletion of the CDR. Three additional unbalanced translocations were found within the CDR and all three breakpoints mapped to a single YAC. We then used a series of P1 arti®cial chromosomes (PACs) spanning this YAC clone, and two PACs produced`split' signals suggesting that they each span one of these breakpoints. Exon trapping using PACs that overlap the breakpoint regions yielded portions of six genes and evaluation of these genes as candidate tumor suppressor genes is underway. The limited information available about these genes suggests that the h-l(3)mbt gene is the most attractive candidate. Oncogene (2001) 20, 4150 ± 4160.
Introduction
Several lines of evidence point to the importance of one or more gene(s) located on the long arm of chromosome 20 whose loss of function contributes to the pathogenesis of multiple myeloid malignancies. Deletion of the long arm of chromosome 20 is a common cytogenetic ®nding in myeloproliferative diseases (MPDs), especially in polycythemia vera (p. vera) patients, where it is often the sole change (Mertens et al., 1991; Aatola et al., 1992; Dewald and Wright, 1995; Mitelman, 1995; Kurtin et al., 1996) . The 20q deletion is also identi®ed cytogenetically in approximately 5% of myelodyplastic syndrome (MDS) patients, and in a fraction of acute myeloid leukemia (AML) cases, generally in association with other abnormalities (Kurtin et al., 1996 , Mitelman, 1995 . Deletion of 20q has been rarely observed in lymphoproliferative disorders (Mitelman, 1995) and in lymphoblastoid cell lines derived from MDS or Ph-positive acute lymphoblastic leukemia patients (Hollings et al., 1995) indicating that the deletion may have occurred in a progenitor cell with both myeloid and lymphoid potentiality Hollings et al., 1994; Knuutila et al., 1994) .
Allelic deletion of microsatellite loci on 20q has been found in only 8% of cytogenetically normal patients with p. vera or myelo®brosis , suggesting that loss of heterozygosity (LOH) is principally due to cytogenetically visible deletions in p. vera. In chronic myelogenous leukemia (CML), LOH of 20q was found at microsatellite loci in 29% of 30 blast crisis patients, comparing DNA from blast crisis phase cells to DNA from chronic phase cells (Mori et al., 1997) ; this suggests that LOH may involve recombination or chromosome loss followed by duplication in these cases. These observations suggest a recessive model of myeloid neoplasia pathogenesis whereby inactivation of a putative suppressor gene(s) on 20q disrupts normal hematopoietic stem cell regulation .
Deletion mapping studies using conventional cytogenetics (Nacheva et al., 1995) , FISH (Roulston et al., 1993) and microsatellite PCR/Southern analysis , have delineated a common deleted region (CDR) within the proximal two-thirds of band 20q12. Wang et al. (1998) narrowed this segment to an area of 8 Mb¯anked by a proximal boundary between markers D20S206 and D20S107, and a distal boundary between D20S119 and D20S424. Allowing for the possibility of multiple culprit genes on 20q, Bench et al. (1998) combined their own data with the Wang data to delineate two overlapping CDRs in patients with MDS or MPD that are 7 ± 8 and 8 ± 9 Mb in size, respectively. A distal boundary common in both diseases was mapped between D20S119 and D20S481, whereas the proximal boundary was found between D20S174 and D20S465 in MPD samples and D20S465 and PLC1 in MDS samples (Bench et al., 1998) .
To further re®ne the commonly deleted region in myeloid malignancies (in particular AML and CML), and identify candidate genes located in the 20q12 region, we obtained and screened a large collection of myeloid leukemia cell lines for large-scale mutations (i.e. homozygous deletion or chromosomal translocation), that can inactivate gene function. Because tumor suppressor gene inactivation often involves mutation (nucleotide substitution, small insertion or deletion) in one copy of the gene, followed by loss of the remaining copy by deletion (Cavenee et al., 1983) , we performed PCR analysis of highly informative microsatellite diand tetranucleotide loci along the long arm of chromosome 20, to identify LOH. Cells exhibiting a mono-allelic pattern of ampli®cation were screened for additional deletions and rearrangements by Southern blot and FISH analyses and three translocation breakpoints were found by FISH in cells from one line (CMK) and were mapped to PAC clones. Subsequent exon trapping experiments using these PAC clones identi®ed six candidate genes which could be involved in the pathophysiology of hematologic malignanices that contain 20q12 abnormalities.
Results

Microsatellite and Southern blot analysis of myeloid leukemia cell lines
Sixty-one of 65 myeloid leukemia cell line DNAs were analysed by PCR at 43 microsatellite loci on chromosome 20, whereas four cell lines (AS-E2, MR-87, NS-MEG, TMM) were evaluated at eleven 20q loci only. A typical PCR generates one or two bands at polymorphic loci in the majority of cell lines, suggesting the presence of both chromosome 20 homologues (see Figure 1 , e.g. HL-60 or TF-1). Allelic imbalance was noted at several scattered heterozygous loci in K562, LAMA-84, SAM-1, TF-1 and HEL cells, which are all erythroid cell lines; the absence of ampli®cation bias involving the smaller alleles at these loci suggests that the allelic imbalance re¯ects an unequal dosage of chromosome 20. Eight cell lines (including CMK and U937, shown in Figure 1) showed ampli®cation of only one allele at multiple adjacent loci, including 19 loci mapping to the CDR de®ned by D20S174 and D20S481 (see Figure 2 ). This phenomenon is most readily explained by the presence of only one chromosome 20 homologue (the presence of two bands at D20S481 in MOLM-1 and at D20S465 in U937 is likely a PCR artifact, as numerous contiguous markers proximal or distal to these loci were found to be homozygous). Four cell lines (CMK, HEL, MONO-MAC-1 and U937) demonstrated interstitial or terminal deletions, with breakpoints mapping centromeric to marker D20174, which is located at the proximal end of the CDR de®ned using MPD patient samples (Figure 2) . A mono-allelic pattern was found at all 20q and 20p loci in the KBM-5 and KBM-7 cell lines and for all but one marker in MEG-O1 and MOLM-1 cells, suggesting reduction to monosomy for chromosome 20. Microsatellite instability (indicated by the laddering of PCR products) was detected at many dierent loci in MKB-1 and RC-2A cells, whereas it was occasionally observed in KCL-22 cells (data not shown).
PCR-based ampli®cation failed repeatedly at D20S110 in CMK cells, at D20S836 in U937 cells, and at D20S881 in MEG-O1 cells, however new sets of primers in nested or semi-nested ampli®cation reactions (see Materials and methods), led to successful ampli®cation at D20S110 and D20S836; however ampli®cation at D20881 failed repeatedly, suggesting the presence of a homozygous deletion at this locus, which was con®rmed by Southern blot analysis (Figure 3) . To identify additional homozygous deletions or intragenic rearrangements contained within the CDR, Southern blots containing EcoRI and HindIII-digested genomic DNA from the eight mono-allelic cell lines were probed using a set of 37 cDNA clones (corresponding to 27 UniGenes and 10 anonymous ESTs) characterized for hybridization to single copy sequences and correct chromosomal mapping ( Table  1 ). The advantage of screening EST markers, compared to STS markers, is that they are more likely to detect functionally signi®cant deletions aecting expressed genes. However, this analysis failed to uncover additional homozygous deletions or smaller rearrangements.
FISH analysis of cell lines
To identify large rearrangements, FISH was applied to the eight mono-allelic cell lines, using eight YAC clones localizing to the CDR de®ned by¯anking markers D20S174 and D20S119 (808C5, 804C12, 834H3, 936E4, 912C3, 777D11, 909F8, 958C12) and one telomeric YAC clone (845H4). For each cell line, at least two YAC probes were used along with CEP20 and WCP20.
Two cell lines (CMK and MONO-MAC-1) showed rearrangements within the CDR. In CMK cells, two populations were found with a tetraploid modal chromosome number. In population I (60% of the cells), ®ve unbalanced rearrangements were identi®ed as der (20)t(1;20)(q31;q11)x2, der(1)t(1;20)(p32;q12), EcoRI and/or HindIII-digested genomic DNA from myeloid leukemia cells was hybridized with a probe speci®c for the D20S881 locus, and control probes for MYBL2 and thrombomodulin (THBD) genes, which locate telomeric and centromeric to D20S881, respectively. A hybridization signal at D20S881 (using a 341 bp probe generated by PCR using D20S881-2f and -2r as primers) is observed in control cells (KBM-5, KBM-7, MOLM-1), but is absent in MEG-O1 cells despite equal loading of DNA Mapping of genes at translocation breakpoints in 20q12 D MacGrogan et al der(6)t(6;20)(p11;q13), der(13)t(13;20)(p11;q12)x4 and a marker chromosome (mar1) (Figure 4a ). None of the YACs showed signals in the der(20)t(1;20)x2, suggesting that this rearrangement was accompanied by a deletion involving the entire CDR (which may explain the mono-allelic pattern detected by microsatellite PCR). The breakpoints of three rearrangements (the der(1)t(1;20), the der(13)t(13;20)x4 and the mar1) were mapped within YAC clone 912C3 (Figure 4b ). 777D11 and 909F8 are YAC clones that overlap with the telomeric end of 912C3 and both clones were found to span the der(13)(13;20)x4 and the mar1 breakpoints. Using centromeric YACs 808C5, 834H3, and 936E4, only two cytogenetically normal chromosome 20 were detected. The telomeric YAC clone 845H4 detected the der(6)t(6;20) and the der(13)t(13;20)x4 rearrangements. Population II of CMK (40% of the cells) contained the der(20)t(1;20)(q31;q11)x2 and the der(13)t(13;20) (p11;q12)x4, but lacked the der(1)t(1;20), the der(6)t (6;20), and the mar1. We used nine PAC clones with markers common to YAC clone 912C3, which we used as probes for FISH (Table 2) . PAC clone dJ1118N11 spanned the der(1)t(1;20)(p32;q12) breakpoint (see Figure 4c ), whereas PAC clone dJ440H8 spanned the der(13)t(13;20)x4 and the mar1 breakpoints.
In MONO-MAC-1 cells, a cell line with a hyperdiploid modal chromosome number, several unbalanced rearrangements were seen, with deletion of the proximal portion of the CDR (Figure 4d ). YAC clones 808C5 and 804C12 showed only one signal on three cell lines (KBM-5, KBM-7, and U937), despite the presence of only one PCR detectable 20q allele, no cytogenetic loss of material was found (Figure 3h ). Allelic deletion may have occurred by chromosomal loss followed by duplication of the remaining chromosome in these cases.
Identification and expression of genes at translocation breakpoints
Two parallel approaches were taken to identify genes located at or near the translocation breakpoints identi®ed in CMK cells by dJ1118N11 [the der(1)t(1;20) breakpoint] and dJ440H8 [located at both the der(13)t(13;20)x4 and mar1 breakpoints]. First, DNAs from a series of PAC clones that overlap dJ1118N11 and dJ440H8 were hybridized by Southern analysis to EST probes previously mapped to YAC clone 912C3 (Table 1) . Hence, IMAGE clones 42082,1676403, and 490234 containing portions of human l(3)mbt (h-l(3)mbt), CGI-53, and MYBL2 genes, respectively, mapped by Southern analysis to a region that contains several contiguous PACs that overlap with clone dJ1118N11 (Table 3) . IMAGE clones 79307 and 41332, which contain portions of the sts-T63166 and TNRC9/CAGF9 genes, respectively, were mapped to several PAC clones that encompass clone dJ440H8.
A second approach involved exon-trapping, using overlapping PAC clones at or near the translocation breakpoints, to identify sequences previously mapped by Southern, as well as potentially novel expressed sequences. The exon-trap products for PAC clone dJ637C15 (overlapping with dJ1118N11) yielded a portion of a serum-glucocorticoid regulated kinase gene (SGK), in addition to exons from the CGI-53 and h-l(3)mbt genes. These exon sequences matched sequences in dJ138B7 (partially overlapping with dJ1118N11) in a BLAST analysis. Using dJ1028D15 (which is overlapping with dJ1118N11), exons for MYBL2 were trapped and using two PAC clones that overlap with dJ440H8 (dJ495O3 and dJ1108D11), we found the previously mapped EST marker (sts-T63166), and the TNRC9/CAGF9 gene; the presence of these genes in these PACs was con®rmed by BLAST search. Querying the UniGene database at NCBI provided information that four UniGene clusters, which correspond to the h-l(3)mbt, CGI-53, MYBL2 and TNRC9/CAGF9 genes, are contained in many dierent cDNA libraries demonstrating that they are actively transcribed genes rather than processed pseudogenes. The EST marker sts-T63166 was found Four of the candidate genes (h-l(3)mbt, CGI-53, SGK and TNRC9/CAGF9) were found to be expressed in human placenta, in bone marrow (BM) and in CMK cells by RT ± PCR (Table 4) . MYBL2 expression was found in CMK cells by Northern blot analysis, and sts-T63166 expression was detected in placenta but not BM or CMK cells by RT ± PCR.
Discussion
The large size and complexity of 20q deletions in primary samples and the availability of hundreds of EST markers and genomic clones mapped to chromosome band 20q12, prompted us to screen a large collection of cell lines derived from AML and CML patients in blast crisis for deletions and rearrangements that would help narrow the consensus region of deletion and facilitate the identi®cation of candidate genes. The frequency and nature of allelic deletions of 20q in the present set of myeloid leukemia cell lines is largely consistent with previous studies of primary samples, which serves to validate our approach. Allelic losses were detected in four of 20 CML blast crisis cell lines (20%), which is slightly lower than the 29% incidence of allelic loss detected in CML blast crisis patient samples (Mori et al., 1997) . Among 42 AMLderived cell lines, allelic losses were found in one AML M5 (MONO-MAC-1), one AML M6 (HEL), and one AML M7 (CMK) cell line, indicating no association with any particular FAB subtype. Consistent with these observations, deletions of 20q were represented in myelo-monocytic (four of 18) as well as megakaryocytic/erythrocytic (four of 25) cell lines. Three of the four allelic losses seen in CML occurred by mitotic nondisjunction, with or without reduplication, which is thought to be the principal mechanism of 20q-associated LOH in CML patients (Mori et al., 1997) . In contrast, LOH was associated with cytogenetically visible rearrangements or deletions of 20q in AML cells, similar to the abnormalities found in p. vera and MDS or AML patients (Wang et al., 1998) . The variable nature of allelic losses found in p. vera, MDS, AML and blast crisis of CML may re¯ect the existence of separate target gene(s) on 20q .
The unique homozygous deletion found at D20S881 in MEG-O1 cells is, to our knowledge, the ®rst homozygous deletion to be identi®ed on chromosome arm 20q in any neoplastic cell type. The ®nding of homozygous deletions in cultured cells or cultured xenografts derived from patient samples, has greatly facilitated the detection and cloning of tumor suppressor genes critical to the pathogenesis of solid tumors (Nobori et al., 1994; Schutte et al., 1995) . Homozygous deletions are rare in hematological malignancies, although they have been found at sites of frequent allelic loss, including 9p21 in acute lymphoblastic leukemia (Hirama and Koeer, 1995) and 13q14 in B-Cell chronic lymphoblastic leukemia (Liu et al., 1995) , both of which are known tumor suppressor loci. Homozygous deletions have been found also in regions of inherent DNA instability or at fragile sites associated with chromosomal rearrangements in cancer cells (Paige et al., 2000) , neither of which have been reported for chromosome band 20q12. AML, acute myeloid myeloid leukemia; CML, chronic myeloid leukemia; -myBC, myeloid blast crisis; -megBC, megakaryocytic blast crisis; -lymBC, lymphoid blast crisis; RAEB, refractory anemia with excess blasts; RAEB-t, RAEB in transformation.
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Mapping of genes at translocation breakpoints in 20q12
The signi®cance of the homozygous deletion identi®ed here is uncertain because it was found to involve only one microsatellite marker locus, that is located outside of the consensus region of deletion de®ned using patient samples (Wang et al., 1998; Bench et al., 1998) . Bench and colleagues examined 28 patient samples with 20q loss by PCR at 32 STS markers located within the CDR and they did not uncover any homozygous deletions (Bench et al., 1998) . Our Southern blot analysis of this region in eight monoallelic 20q cell lines did not detect any additional deletions or intragenic rearrangements at 37 genes/ ESTs. Given that 20q12 is a Giesma-staining dark band, which is predicted to be gene-poor (Strachan and Read, 1996) , the average EST density of 4 ± 5 Mb used in our screen may have been sucient to cover most genes located within the CDR, although smaller deletions may still be missed.
The analysis of CMK cells revealed allelic loss due to an unbalanced rearrangement accompanied by a series of unbalanced translocations in the remaining allele. The translocation breakpoints in the remaining allele map within the minimally deleted region in myeloid malignancies as de®ned by LOH and cytogenetic deletion, and as such, may have disrupted one copy of a putative myeloid leukemia tumor suppressor gene. A precedent for a two-hit model involving translocation and deletion of a key gene was found in cells from neuro®bromatosis type 1 (NF-1) patients, where balanced translocations aecting a 17q11.2 breakpoint is accompanied by LOH at the other allele (Fountain et al., 1989) . Subsequent molecular analysis identi®ed a complete loss of expression of the NF-1 tumor suppressor gene, which was interrupted by the translocation (Wallace et al., 1990; Viskochil et al., 1990) . The translocations identi®ed here are unbalanced and found in a cell line that has a highly complex chromosomal pattern. However they are located in the region of recurrent deletion in primary samples, and may be of pathological relevance.
We have identi®ed a set of candidate genes that lie within the 20q-breakpoint regions using Southernbased mapping, exon-trapping, and database searches. These include known and previously mapped genes (MYBL2, TNRC9/CAGF9, h-l(3)mbt) (Noben-Trauth et al., 1996; Margolis et al., 1997; Koga et al., 1999) , a mapped UniGene (CGI-53) (Lai et al., 2000) , an unknown mapped EST (sts-T63166), and an exontrapped transcript not previously mapped (SGK). The h-l(3)mbt gene encodes a member of the polycomb group family of proteins and is the human homologue of a tumor suppressor gene in Drosophila (Koga et al., 1999) . Based on known and putative functions, the h-l(3)mbt is an attractive candidate gene and will be prioritized for mutational and functional analyses. The candidate genes expressed in BM were found transcribed in CMK cells by RT ± PCR or Northern blot analysis, indicating that the rearrangements do not completely eliminate gene expression. However, due to the presence of potentially normal candidate genes on the remaining chromosome 20 which are not disrupted by the der(1)t(1;20), it will be necessary to quantitate the level of candidate gene expression.
During the preparation of this study, Bench et al. (2000) and Wang et al. (2000) have reported narrowing the 20q-CDR using primary patient samples. Bench et al. (2000) de®ned a new region in MDS of 2.6 Mb and in MPD of 2.7 Mb with an overlapping (`myeloid') region of 1.7 Mb. Interestingly this new`myeloid' CDR encompasses both breakpoint regions found in CMK cells, and includes all six candidate genes identi®ed in our study. A new *250 kb MDS/AML region (overlapping with the new MPD region of Bench et al., 2000) , was identi®ed by Wang et al. (2000) but it is located distal to the MDS region de®ned by Bench et al. (2000) . This dierence may re¯ect the fact that the new MDS/AML CDRs were established on the basis of two cases of MDS in the Bench series and two cases in the Wang series (one of AML-M2 and one of MDS); these events may be associated with separate genes.
In summary, we screened numerous myeloid leukemia cell lines and we identi®ed one cell line, CMK, that contains a series of translocations within the CDR found in patients with 20q deletions. We have identi®ed several candidate genes, including a human homologue of a Drosophila tumor suppressor gene (h-l(3)mbt), that may be relevant to myeloid leukemia pathogenesis. Further analysis of the role of these candidate genes in the growth of leukemia cells and the regulated process of normal hematopoiesis is warranted.
Materials and methods
Cell lines and DNA extraction
The cell lines listed in Table 4 were obtained from various laboratories around the world, or were purchased from either the Deutsche Sammlung von Mikroorganismen und Zellkuluren GmbH (Braunswheig, Germany) or the American Type Culture Collection (Rockville, MD, USA). Cell lines were grown in RPMI1640 medium supplemented with 10 ± 20% fetal bovine serum. A list of culture conditions and origin of each cell line will be provided upon request. High molecular weight genomic DNA was prepared from each cell line using standard methods (Sambrook et al., 1989) .
PCR-based microsatellite analysis
A set of 43 microsatellite markers on chromosome 20 (42 dinucleotide and one tetranucleotide) with a mean heterozygosity value of 0.76 (range 0.5 ± 1), was identi®ed at the Whitehead Institute/MIT Center for Genome Research Human Physical Mapping project (Dib et al., 1996) (http:// www-genome.wi.mit.edu/). Premade pairs of oligonucleotides were obtained from Research Genetics (Huntsville, AL, USA) (ftp://ftp.resgen.com/pub/mappairs/human/human.txt) and additional primers were designed for the following loci: D20S110 (http://gdbwww.gdb.org/gdb/, sequence accession no. Z16791; D20S110-2f, 5'-AGGTTTGACAGCCAAATG-3' and D20S110-2r, 5'-TTACCACAAACTTGTGAACTA-GA-3'), D20S881 (accession Z53346; D20S881-2f, 5'-CAG-CACAAAAGGCAGAGGA-3' and D20S881-2r, 5'-AGA-CTTTGAGGTTGGGGTGA-3'), and D20S836 (accession Z52210; D20S836-2f, 5'-CTAAGAGCAGCCTCCCCATC-3' and D20S836-2r, 5'-ACTAGATGCCAGCAGCACAC). One oligonucleotide for each primer pair was end-labeled using T4 polynucleotide kinase (New England Biolabs) and [g 33 P]dATP (Sambrook et al., 1989) , and the PCR reactions were performed in 10 ml volumes containing 50 ng of template DNA, 25 ng of each primer, Taq DNA polymerase and other constituents in the buer supplied (Gibco ± BRL). Conditions for ampli®cation were 948C for 2 min, followed by 30 cycles of 948C for 15 s, 558C for 15 s and 728C for 30 s, followed by a ®nal extension reaction at 728C for 8 min. The ampli®ed products were separated by 6% denaturing polyacrylamide gel electrophoresis.
YAC and PAC clones
Sixteen mega YAC clones spanning the interval between D20S174 and D20S119 were obtained from commercial sources (Research Genetics, Genome Systems, St Louis, MO, USA) and from the Centre d'Etude du Polymorphisme humain (CEPH, Paris, France), and sized by pulse ®eld gel electrophoresis. The order of the YACs has been reported as q-cen-942B1-808C5-804C12-834H3-925D5-889A-936H3-936E4-777D11-905D3-912C3-951F2-909F8-742F1-958C12-800A11-q-tel (Stoel et al., 1996; Bench et al., 1998) and was largely con®rmed by us by STS/probe mapping. Eleven PAC clones were obtained from the BAC/PAC Resource Center at Roswell Park Cancer Institute and PAC DNA was prepared using a Qiagen Plasmid Midi kit (Qiagen, Chatsworth, CA, USA). The order of the PAC clones was determined at the Sanger Centre as q-cen-dJ138B7-dJ637C15-dJ1118N11-dJ1028D15-dJ453O10-dJ622K8-dJ11N4-dJ495O3-dJ440H8-dJ1118N6-dJ1108D11-q-tel (http://webace.sanger.ac.uk/cgibin/ace/pic/20ace?name=Chr 20ctg125&class=Map).
Characterization of cDNA clones
A set of 90 Expressed Sequence Tags (ESTs) derived from 73 UniGene clusters was identi®ed at the National Center for Biotechnology Information (NCBI) Human Gene Map Project (http://www.ncbi.nlm.nih.-gov/genemap/) using D20S174 and D20S119 as proximal and distal interval endpoints, respectively. Plasmid clones were obtained from the IMAGE collection from commercial sources (Research Genetics, Genome Systems). Complementary DNA (cDNA) inserts were radiolabeled with a 32 P-dCTP, by the random priming method, and serially hybridized in RapidHyb buer to nylon membranes containing genomic DNA from the 15 YAC clones and control DNA obtained from mouse A9/ human chromosome 20 hybrid cells (GM13260), from parental A9 cells (GM00346) (both obtained from NIGMS Human Genetic Mutant Cell Repository, Coriell Institute, Camden, NJ, USA), and from human placenta DNA (Sigma, St Louis, MO, USA). Final washes were in 0.16SSC, 0.5% SDS at 688C, and membranes were then exposed to Kodak Biomax MS ®lms overnight. Characterization of the IMAGE clones by these methods yielded 34 single copy probes, mapping to the D20S174-D20S119 interval (*26% of the clones tested). The identities of several clones were also con®rmed by single passage DNA sequencing. Three cDNA clones were obtained for hTOM34 (SD Nuttall), hHNF4A (I Talianidis), and STK4 (CL Creasy).
Fish
YAC and PAC DNAs were labeled by nick translation with Bio-14-dATP (Gibco ± BRL). Metaphase preparations from control normal human lymphocyte and leukemic cell lines were pretreated with 26SSC at 378C for 1 h and dehydrated in a graded ethanol series. Slides were denatured in 70% formamide, 26SSC at 758C for 2 min, followed by dehydration in a cold ethanol series. Labeled probe DNA (300 ng/ml), along with 12 ml of hybridization mixture (50% formamide/26SSC, 10% dextran sulfate, and Denhardt's) and 2.5 mg of Cot-1 DNA (Gibco ± BRL), was denatured at 708C for 7 min, pre-annealed at 378C for 10 min and applied to the slide. Each probe was co-hybridized along with the centromeric (CEP20) or painting probe for chromosome 20 (WCP20) (Vysis, Downers Grove, IL, USA). Hybridization was carried out overnight at 378C followed by washing with 50% formamide/26SSC (10 min) and 26SSC (10 min) at 428C. Labeled probes were detected with avidin-conjugated uorescein isothyocyanate (avidin-FITC) and biotinylated anti-avidin (Oncor, Gaithersburg, MD, USA). Slides were counter-stained with 4'6'-diamideno-2-phenylindole (DAPI, Oncor). Analysis was performed using a Nikon¯uorescence microscope equipped with a CCD camera with Smartcapture View Point multicolour imaging station software (Digital Scienti®c). Seventeen to 74 metaphases and 400 interphases were scored for each cell line.
Exon trapping
Exon trapping was performed using the Exon Trapping System (Gibco ± BRL) essentially as described by the manufacturer. Brie¯y, PAC DNA was restriction digested with HindIII and BamHI and products from each reaction were ligated into pSPL3. Ligation products were transfected into COS-7 cells using Lipofectamine (Gibco ± BRL), and after 24 h, total RNA was isolated by the guanidineisothiocyanate method (Sambrook et al., 1989) . Reversetranscribed RNA was generated using Superscript Reverse Transcriptase (Gibco ± BRL) and the products PCR-ampli®ed and digested with BstXI in order to eliminate vector-derived products. After a second round of ampli®cation, PCR products were separated on 2% agarose gels and individual bands excised and subcloned into pAMP10. Inserts were sequenced and analysed using the BLAST program (Altschul et al., 1990) against the non-redundant database at NCBI.
Reverse transcription-polymerase chain reaction and Northern blot analysis
Total RNA was extracted from CMK cells using Tri-reagent (Sigma) per the manufacturer's instructions. Total RNA from human placenta was obtained from Research Genetics and bone marrow RNA was obtained from Clontech, (Palo Alto, CA, USA). Reverse transcription and PCR were performed using a GeneAmp kit (Roche Molecular Systems, Branchburg, NJ, USA), under conditions recommended by the manufacturer (with minor modi®cations). Brie¯y, reactions were carried out using 1 mg of RNA in a 20 ml volume containing 16PCR buer II, 2.5 mM oligodT, 1 mM of each dNTP, 5 mM MgCl 2 , 20 U Rnase inhibitor and 50 U reverse transcriptase, at 428C for 20 min. In each case, a reaction was performed in the absence of reverse transcriptase to control for genomic DNA contamination. Samples were heated at 988C for 5 min then chilled on ice; 2 ml aliquots were PCRampli®ed in 20 ml reactions consisting of 16PCR buer II, 2 mM MgCl 2 , and 0.5 U AmpliTaq DNA polymerase for 33
